Synapse - Works

Results (1860)

Defining the balance of anti-viral and anti-tumor T cell responses to oncolytic virus therapy using single cell approaches

Meeting Abstract

Burman, B.; Ceglia, N.; Hirschhorn, D.; Budhu, S.; Mangarin, L.; Oseledchyk, A.; Bykov, Y.; McPherson, A.; Shah, S.; Wolchok, J.; more...
Cancer Research (2022)

Fulltext@MSK | Save

MCT4 blockade reverses lactate-mediated immunosuppression in LKB1-deficient NSCLC

Meeting Abstract

Qian, Y.; Guijarro, I.; Galan-Cobo, A.; Dang, M.; Poteete, A.; Zhang, F.; Wang, Q.; Wang, J.; Parra, E.; Skoulidis, F.; more...
Cancer Research (2022)

Fulltext@MSK | Save

Examining the impact of chromosomal instability on mucosal melanoma tumor infiltrate and responses to PD-1 based therapy

Meeting Abstract

Armstrong, E.; Gottesdiener, L.; Schultz, N.; Bakhoum, S. F.; Hollmann, T. J.; Shoushtari, A.
Cancer Research (2022)

Fulltext@MSK | Save

Pharmacologic inhibition of the glycolytic pathway improves response to immune checkpoint blockade

Meeting Abstract

Verma, S.; Serganova, I.; Budhu, S.; Dong, L.; Ko, M.; Mangarin, L.; Merghoub, T.; Wolchok, J.; Zappasodi, R.
Cancer Research (2022)

Fulltext@MSK | Save

APR-246 enhances tumor immunogenicity even in the absence of p53

Meeting Abstract

Venkatesh, D.; Michels, J.; Liu, C.; Budhu, S.; George, M. M.; Abrahmsen, L.; Zappasodi, R.; Wolchok, J. D.; Merghoub, T.
Cancer Research (2022)

Fulltext@MSK | Save

Modulation of immune gene expression by intra-tumoral oncolytic adenovirus ONCOS-102 is associated with clinical response in anti-PD-1 refractory/resistant melanoma

Meeting Abstract

Wiklund, E. D.; Kuryk, L.; Kumar, S.; Jaderberg, M.; Levitsky, V.; Hansen, T. B.; Moller, A. S.; Shoushtari, A.
Cancer Research (2022)

Fulltext@MSK | Save

Combining a novel MEK inhibitor with immunomodulation to promote an anti-tumor response

Meeting Abstract

Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Verma, S.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
Cancer Research (2022)

Fulltext@MSK | Save

Oral beta-glucan enhanced anti-ganglioside antibody titer after vaccination against high- risk neuroblastoma: Results of a randomized trial

Meeting Abstract

Cheung, I. Y.; Mauguen, A.; Feng, Y.; Ragupathi, G.; Basu, E.; Roberts, S. S.; Modak, S.; Kushner, B. H.; Cheung, N. K. V.
Cancer Research (2022)

Fulltext@MSK | Save

Deferiprone alters macrophage function and metabolism

Meeting Abstract

Ackerstaff, E.; Budhu, S.; Winkleman, D. P.; Min, S. S.; Ijoma, J. N.; Serganova, I. S.; Blasberg, R. G.; Merghoub, T.; Koutcher, J. A.
Cancer Research (2022)

Fulltext@MSK | Save

Combination of cyclophosphamide with immune checkpoint blockade inhibition elicits potent tumor control in a preclinical melanoma model

Meeting Abstract

George, M. M.; Warner, A. B.; Hamadene, L.; Hirschhorn, D.; Houghton, A. N.; Wolchok, J. D.; Merghoub, T.
Cancer Research (2022)

Fulltext@MSK | Save